Sumatriptan for migraine attacks in children: A randomized placebo- controlled study. Do children with migraine respond to oral sumatriptan differently from adults?

Neurology

Volumn 48, Issue 4, 1997, Pages 1100-1103

  Hämäläinen, Mirja L ^a   Hoppu, Kalle ^a   Santavuori, Pirkko ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SUMATRIPTAN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENZYME METABOLISM; FEMALE; HUMAN; MALE; MIGRAINE; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0342683795     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.4.1100     Document Type: Article

References (16)

1. Singer HS. Migraine headaches in children. Pediatr Rev 1994; 15:94-101.
2. Bateman DN. Sumatriptan. Lancet 1993;341:221-224.
3. Korsgaard AG, on behalf of the Study Groups. The tolerability, safety and efficacy of oral sumatriptan 50 mg and 100 mg for the acute treatment of migraine in adolescents. Presented at the 3rd International Congress on Headache in Childhood and Adolescence, May 4-6, 1995, Budapest.
4. MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache 1994;34:581-582.
5. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):1-96.
6. Hämäläinen ML, Hoppu K, Santavuori PR. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology 1997;48:103-107.
7. Hämäläinen ML, Hoppu K, Santavuori PR. Oral dihydroergotamine for therapy-resistant migraine attacks in children. Pediatric Neurology (in press).
8. Tanner JM. Development of reproductive system. In: Tanner JM, ed. Growth at adolescence. 2nd ed. Oxford: Blackwell, 1962:28-39.
9. Sriwatanakul K, Kelvie W, Lasagna L, Calimlim JF, Weis OF, Mehta G. Studies with different types of visual analog scales for measurement of pain. Clin Pharmacol Ther 1983;34:234-239.
10. Littman GS, Walker BR, Schneider BE. Reassessment of verbal and visual analog ratings in analgesic studies. Clin Pharmacol Ther 1985;38:16-23.
11. Gardner MJ, Altman DG. Statistics with confidence - confidence intervals and statistical guidelines. London: BMJ, 1989.
12. Goadsby PJ, Zagami AS, Donnan GA, et al. Oral sumatriptan in acute migraine. Lancet 1991;338:782-783.
13. Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 1995;346:923-926.
14. Beyer JE, Wells N. The assessment of pain in children. Pediatr Clin North Am 1989;36:837-854.
15. Dixon CM, Park GR, Tarbit MH. Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver. Biochem Pharmacol 1994;47:1253-1257.
16. Bille B. Migraine in childhood and its prognosis. Cephalalgia 1981;1:71-75.